Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
about
Natriuretic Peptides and Cardiometabolic HealthRole of corin and atrial natriuretic peptide in preeclampsiaAtrial natriuretic peptide in cardiovascular biology and disease (NPPA)Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient miceRapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overloadCardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B.Novel and effective gene transfer technique for study of vascular renin angiotensin system.Dendroaspis natriuretic peptide induces the apoptosis of cardiac muscle cells.Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.Functional interaction of NF-Y and Sp1 is required for type a natriuretic peptide receptor gene transcription.GREBP, a cGMP-response element-binding protein repressing the transcription of natriuretic peptide receptor 1 (NPR1/GCA).Endogenous vascular synthesis of B-type and C-type natriuretic peptides in the rainbow trout.ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models.Blood pressure and human genetic variation in the general population.Role of nitric oxide in progression and regression of atherosclerosisCardiac natriuretic peptides--hope or hype?Water deprivation stimulates transforming growth factor-beta 2 accumulation in the juxtaglomerular apparatus of mouse kidney.Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growthRegulation of apoptosis by vasoactive peptides.Natriuretic peptides in relation to the cardiac innervation and conduction system.Structure, signaling mechanism and regulation of the natriuretic peptide receptor guanylate cyclase.Nesiritide: a novel approach for acute heart failure.Increased atherosclerosis and smooth muscle cell hypertrophy in natriuretic peptide receptor A-/-apolipoprotein E-/- mice.Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension.The C2238/αANP variant is a negative modulator of both viability and function of coronary artery smooth muscle cells.Atrial natriuretic peptides: anticancer agents.Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.Vasoactive peptides in cardiovascular (patho)physiology.Physiology and clinical significance of natriuretic hormonesDifferential effects of natriuretic peptides on arterial and venous coronary artery bypass conduits.NPR3 protects cardiomyocytes from apoptosis through inhibition of cytosolic BRCA1 and TNF-α.Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications.Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension.Natriuretic peptides in cardiometabolic regulation and disease.Discovering a new role for the atrial natriuretic peptide: A novel risk factor for cardiovascular diseases.Inhibition of vascular smooth muscle cell proliferation and migration in vitro and neointimal hyperplasia in vivo by adenoviral-mediated atrial natriuretic peptide delivery.Attenuation of inhibitory effect of CNP on the secretion of ANP from hypertrophied atria.Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system".Atrial natriuretic peptide attenuates ANG II-induced hypertrophy of renal tubular cells.Neutral endopeptidase (NEP) inhibition in rats with established pulmonary hypertension secondary to chronic hypoxia.
P2860
Q26827702-C975ABEE-514B-4D63-873E-421CF9F738AFQ27022988-4ED5AD69-C5D5-4721-88EB-6E42925CEB66Q28082833-350A9B9B-2359-44A8-B62A-2FDEF40175A7Q28362795-01B5D879-67EE-478C-BEC1-ECCBE7F76F1BQ28568167-242652E0-2DCC-43E2-A48C-C2D1AAA13777Q28569799-F409181B-4669-43CB-8F31-5F4849DD01DBQ30449287-75D53136-F867-4AB3-86E0-16F918D904E2Q33213493-E63B3F84-FABD-4B1F-9DF9-CABA63D6FBB9Q33900223-96609567-1D83-4C94-B798-BD7311CCFF36Q33920484-A9EAAC34-134B-4B53-8508-B4F0395D8A04Q33966980-BEBE29D4-7A1D-4141-8E0F-3236731BAF83Q33973358-A143C47D-FDDE-4040-B74A-B66B87C2BF5CQ34051679-D22743D4-1A23-4308-9994-709389936E7DQ34163961-24A933E9-D661-4A8A-ABAB-B3337DB81690Q34183363-E6CDBB8B-8081-4337-8B72-637D944E07D9Q34207401-738A64EB-B0BB-4DFF-994C-CE2A76A37805Q34217142-866B2E73-8105-420A-BB4F-7840144738CCQ34229552-2F4DDF7C-F1A7-49C4-AEE7-9180C11D630CQ34369962-0C61F539-3956-4B0F-BD1B-60FF509A4B97Q34845237-64904059-213A-4655-92CF-2458AE8ABAD2Q34990290-40AB1DC0-5056-4CED-A21A-0565D2F624CDQ35054263-1E849F1E-7FE0-4DD9-98EB-01B8FAEA6D83Q35064440-17673C3B-F752-4F41-BC48-86B3BE4E776DQ35214142-9863CDE1-29D6-4F20-BD68-6B08ADB00836Q35425744-01F45F9A-9CFC-4039-8F8D-33D34E110A5AQ36317199-8C1599B0-D511-4CA7-A328-8364D1F12BFCQ36534829-88BB2EF0-A871-41EC-92F8-1E2C6371EFA1Q36815987-B280C26B-B9B1-47EB-B0FA-D5BF71EEB155Q36862282-9A72DF45-1A08-4B47-9E03-C15431F6A95DQ37226897-E4A1467F-BBC9-4BB4-BDBB-64AF06FF0B94Q37262907-E6EF07E4-9B77-4099-BC5F-2115ABF372A2Q37626852-DDA3A0FF-BFD8-4B05-8F96-C6E9D6E802E9Q38112038-1882FB98-A277-45A7-A248-35DBD2BA8126Q38211333-C518D56D-D364-4D40-A1CD-BEC4127E53ECQ38605411-73B08CDF-62F3-4EC4-BFAC-5014B4ACA328Q39340200-3987E810-9EAE-423A-8BDC-94C4E11F3991Q39413635-A0AF3BC8-D18A-4166-A607-27B30527D338Q40512524-70542A65-16FA-42F0-BCE8-81E39B1319D0Q40799480-04A548FC-FB24-4871-B28C-145081882FC6Q41855040-DA232E6F-2C68-45A0-AB2E-D62D85242F2A
P2860
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
description
1990 nî lūn-bûn
@nan
1990 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
@ast
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
@en
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
@nl
type
label
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
@ast
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
@en
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
@nl
prefLabel
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
@ast
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
@en
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
@nl
P2093
P2860
P356
P1476
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
@en
P2093
P2860
P304
P356
10.1172/JCI114893
P407
P577
1990-11-01T00:00:00Z